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Summary
Safety testing of veterinary vaccines requires the use of a large number of animals to investigate possible local and 
systemic reactions. This includes, among others, the pathological examination of the injection site in frequent intervals. 
This examination requires a selected killing of animals in frequent intervals. To reduce the number of animals needed 
for this kind of safety testing, magnetic resonance imaging (MRI) was used to detect and quantify possible local 
reactions after vaccination in vivo. Sixty-four pigs were divided into four experimental groups (n = 16); two groups 
consisting of 12-week-old pigs and two of 6-month-old pigs at vaccination day. The pigs were vaccinated with four 
licensed products (each group receiving one vaccine) and examined up to 6 times using MRI during a period of 
5 weeks. The MR images were evaluated semi-automatically, comparing the volumes of altered signal intensities on 
the vaccination side (VS) with the volumes of the signal intensities on the control side (CS). A paired t-test was used to 
identify significant differences (p < 0.05) between VS and CS. The results show that MRI allows a 3D-quantification 
of the extent of local reactions in vivo by scanning the same live animals at several time points after vaccination. MRI 
is a suitable alternative method for non-invasive safety testing of injectable medicines and can therefore be applied to 
reduce animal numbers used for safety testing purposes.
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1  Introduction
Safety testing in animals is an important part of the licensing 
procedure for veterinary vaccines required by the European 
Pharmacopoeia and other legal regulations, such as Directive 
2001/82/EC (EDQM, 2008; EC, 2001). For these regulatory 
tests a large number of animals is needed, because every target 
animal species and category, for which the use of a medicinal 
product is intended, has to be tested. Currently, some animals 
have to be euthanized in frequent intervals after vaccination 
in order to perform a pathologic examination of the vaccina-
tion site (EC, 2001). Alternative approaches are needed to 
reduce animal numbers used for regulatory purposes as is de-
manded by the World Health Organization (WHO). The WHO 
demanded minimization of the use of animals and pushed 
forward the use of alternative methods which reduce, refine 
or replace animal testing, i.e. the 3R principle (Stokes et al., 
2011; Russel and Burch, 1959). 
This study was conducted in order to minimize the number 
of animals used in safety testing of veterinary vaccines ac-
cording to the 3R principle. Magnetic resonance imaging 
(MRI) was investigated as a possible alternative method to 
detect and to evaluate vaccination-induced local reactions at 
the injection site in the living animal at several time points 
after vaccination. In human medicine imaging methods like 
MRI, computer tomography (CT) and ultrasound (US) are ap-
proved methods for clinical studies of muscular disorders like 
inflammation, denervation, mass lesions and their follow-up 
(Kuo and Carrino, 2007; Reimers, 1990; Schedel et al., 1992; 
Walker, 2008). Because of its higher sensitivity, a better con-
trast resolution and the use of non-ionizing radiation, MRI 
became the method of choice for soft tissue imaging (Fisher et 
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al., 1986; Lovitt et al., 2006; Nägele and Hahn, 1990; Tanttu 
and Sepponen, 1996). 
The body of a patient consists mainly of muscle, fat, connec-
tive tissue and bone. All tissues are mainly built up on protons 
(1H+ ion). The signal of an MR image is based on the proton 
distribution, density, relaxation time after a radio frequency 
impulse and spin “behavior” inside the patient’s body (Pipe, 
1999; Hodgson, 2010). The grey scale of a tissue in MR images 
depends on the intensity of the signal and therefore on intrin-
sic properties, which change depending on the tissue condition 
(Hodgson, 2010; Tanttu and Sepponen, 1996). Muscle signal 
intensity can be affected by various conditions such as trauma, 
infection or inflammation. These abnormalities effect an altera-
tion in tissue parameters and cause differences in signal inten-
sity in the image, as well as in muscle size and profile (Lovitt 
et al., 2006; May et al., 2000; Schrank et al., 2005). The ability 
to detect these alterations makes MRI a useful tool in diagnosis 
and follow-up of musculoskeletal diseases in humans (Lovitt et 
al., 2006; Messineo et al., 1998). 
For clinical safety studies in veterinary medicine the use of 
MRI is in most cases limited to pet animals. Investigations using 
farm animals are rare. This study utilized MRI in pigs to inves-
tigate vaccination-induced local reactions. The repeated moni-
toring of animals in vivo by MRI, resulting in well-documented 
clinical data, should allow a reduction in the number of animals 
needed to perform the safety testing for veterinary medicines.
2  Animals and methods
Animals, management and testing scheme
The study was conducted at the Livestock Center Obersch-
leissheim of the Veterinary Faculty of the Ludwig-Maximil-
ians-University in Munich. For this study a total of 64 pigs 
were used. The number of animals and the experimental set-up, 
including housing, keeping and feeding, was conducted in ac-
cordance with the District Government of Upper Bavaria (reg-
istration number: 55.2-1-54-2532-138-11) and were in compli-
ance with local and national guidelines and reported in detail 
according to the ARRIVE guidelines (Kilkenny et al., 2010). 
The animals were kept according to the national animal welfare 
law (Germany, 2013) and the German Animal Welfare Regula-
tion for Livestock Housing (German Federal Ministry for Food, 
Agriculture and Consumer Protection, 2009). All animals were 
crossbred offspring from Piétrain sires and German Landrace 
sows, randomly divided into experimental groups as outlined 
in Table 1. No separate randomization was performed, because 
each pig was control and treatment animal at the same time. 
Only healthy pigs originating from a crossbred litter entered 
the experiment. 
The pigs were born and raised at the Livestock Center. The 
animals grew up and were treated like all other pigs. At an age 
of four weeks, piglets were weaned and moved to a nursery deck 
where they were housed in groups of 15-22 animals (0.65-0.75 
m2 per animal). All boxes were enriched with balls and metal 
chains, which can be moved and changed as required in the Ger-
man Animal Welfare Regulation for Livestock Housing (Ger-
man Federal Ministry for Food, Agriculture and Consumer Pro-
tection, 2009) to satisfy their exploration drive. At a body weight 
of 25-30 kg, the pigs were moved to an outdoor-climate barn and 
housed in group pens combined of deep straw bedding in the rest 
area and concrete slatted flooring in the feeding area, providing 
an individual space of > 0.8 m2. All pigs were fed with a specific 
diet (11-13 MJ/kg of ME age-related) twice a day.
Three weeks before the animals reached the specific age for 
vaccination all pigs were marked with a tattoo needle, creating 
a circle (diameter 0.3 cm) on the neck skin behind the left ear. 
This was performed in order to mark the injection point perma-
nently for the whole examination period (see Fig. 1). One day 
before vaccination, the pigs were moved into a barn nearby the 
MRI unit. Inside this facility, the pigs were housed in groups 
of eight pigs in a 12 m2 pen with concrete flooring and straw 
bedding. The pigs were fed only once (morning feeding) on the 
day before scanning and received no food on the examination 
day in order to prepare a secure anesthesia and avoid vomiting 
and swallowing during general aesthesia. Access to water was 
given ad libitum. 
All pigs were vaccinated into the middle of the tattoo circle 
(day 0). The groups differed regarding their age at vaccination 
day (group I + II: 12 weeks old; group III + IV: six months old) 
and the vaccines used. All vaccines differed in their composi-
tion such as antigens, adjuvants, preservatives and other ad-
ditives (see Tab. 2). All animals were test and drug naïve and 
had not been vaccinated with the used antigen before. Vaccines 
were administered by using specific needles according to the 
age of the pig (group I: 16G x ¾, Ideal Instruments, Neogen; 
group II: 18G x 1, Easy Lance, WDT; group III + IV: 17G x 2, 
Fine-Ject, Henke Hass Wolf). 
Before vaccination the health status of each animal was 
checked. After vaccination (day 0), each animal was scanned 
Tab. 1: Description of the animals in each experimental group
group  number of animals gender  age* (days) weight* (kg)
I 16 male 89 ± 1.02 33.1 ± 4.19
II 16 male 86.13 ± 0.34 29.38 ± 3.66
III 16 female 172 ± 0.45 76 ± 8.22
IV 16 female 171.56 ± 1.21 87 ± 11.61
*on first day of study (day 1) 
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using MRI on days 1, 3, 8, 15, 22 and 29 (see Fig. 1; not all 
groups were examined on all examination days). The examina-
tion procedure was stopped when no reaction could be observed 
any longer at the vaccination site. This resulted in different ex-
amination periods for the experimental animals. The pigs were 
anaesthetized before MRI examination using an intramuscular 
injection of azaperone (2 mg/kg body weight) and ketamine 
(20-40 mg/kg body weight). As all pigs were vaccinated in the 
neck as recommended, the anesthetics and all necessary injec-
tions before day 0 were injected into the muscles of the hind 
leg (Musculus semimembranosus, Musculus semitendinosus) 
to avoid artifacts in the neck region. The health status of each 
pig was checked before injection of anesthetics. 
Sample size
Each experimental group reported here consisted of 16 animals. 
For sample size calculation the GPower software package 3.1 
(Faul et al., 2007, 2009) with an assumed power of 0.8 and an 
effect size of 0.66, which correlates with a large effect size, was 
used. The sample size calculation for a matched paired t-test 
resulted in n = 16. 
Magnetic resonance imaging
An open low-field MRI system (Siemens Magnetom Open; 
0.2 Tesla magnetic field strength) was used for data acquisi-
tion. For the detection of muscle abnormalities, like hemato-
ma, edema or fatty infiltration, different MR imaging proce-
dures can be used, like different T1-weighted and T2-weighted 
image sequences (see Tab. 3). This depends on different re-
laxation times: transversal (T1) and longitudinal (T2) relaxa-
tion time (for further information see Pipe, 1999 or Hodgson, 
2010). Depending on the used sequence weighting, different 
pathologic conditions can be visualized and result in areas 
(volumes) with increased signal intensity (Lovitt et al., 2006; 
May et al., 2000; Schrank et al., 2005). For this study, T1- and 
T2- weighted spin echo sequences with two directions of ac-
quisition (axial and coronary; only results for the coronary ac-
quisition are displayed) were applied (see Tab. 3 and Fig. 2) in 
order to illustrate a wide spectrum of pathologic conditions. 
The following protocol was used for the MRI examination:
1. T1-weighted spin echo sequence with coronary  
acquisition (T1c)
2. T2-weighted spin echo sequence with the same coronary 
acquisition as T1c (T2c)
3. T1-weighted spin echo sequence with axial acquisition (T1a)
(T1 = T1-weighted; T2 = T2-weighted; c = coronary acquisition; 
a = axial acquisition)
During the MRI examination the pigs were bedded in a prone 
position with their front limbs flexed and hind limbs extended. 
The small body coil (for the 12 week old pigs) and the large 
Fig. 1: Sequence of the procedures
Fig. 2: Demonstration of the different acquisition directions
the black lines (inside b & c) demonstrate the acquisition 
directions (coronary and axial). Image (a) shows a pig inside the 
Siemens Magnetom Open, positioned for examination of the pigs’ 
neck. the black lines inside image (b) demonstrate the coronary 
image acquisition. the black lines inside image (c) demonstrate 
axial image acquisition.
Tab. 2: Vaccine ingredients, injection type and injection volume for each group
group age at vaccination day ingredients of the inactivated product   injection type and volume 
  (antigen, adjuvant & preservative)  
I 12 weeks Gonadotropin releasing factor analogon,  subcutaneous, 2 ml 
  diethylaminoethyl-dextran,  thiomersal 
II 12 weeks erysipelothrix rhusiopathiae,  subcutaneous, 2 ml 
  aluminium hydroxide, thiomersal 
III 6 months Parvovirus + erysipelothrix rhusiopathiae I,  intramuscular, 2 ml 
  aluminium hydroxide, thiomersal 
IV 6 months Parvovirus + erysipelothrix rhusiopathiae II intramuscular, 2 ml 
  DL-α-Tocopherolacetate, formaldehyde 
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body coil (for the 6 month old pigs) were used as receivers and 
positioned over the head and neck. Figure 2 shows the position-
ing of the pig and exemplarily the two acquisition directions 
(coronary and axial) of the sequences used. 
Image evaluation
The magnetic resonance images were evaluated using the Able 
3D-Doctor® Software (Able Software Corp., Lexington, MA, 
USA). A regional analysis was performed to evaluate the volume 
of the regions with increased signal intensity at the vaccination 
site (VS; left neck side) and at the control site (CS; right neck 
side). A region of interest (ROI; see white box in Fig. 3) was cre-
ated in order to cover the largest extent of the area with increased 
signal intensity at the VS. Regions with increased signal intensity 
within the ROI were defined by using the interactive segmentation 
function, which segments regions into different tissue classes by 
separating them according to defined signal intensities on a grey 
scale level from 0 (black) - 4096 (white). Regions with increased 
signal intensities or grey values (close to white) were classified as 
hyperintense regions. Within the same image the ROI of the VS 
was mirrored to the CS and the interactive segmentation function 
was applied using the same thresholds for signal intensity as on 
the VS (see Fig. 3). Five images from each sequence – starting at 
the injection point – were evaluated accordingly. 
Fig. 3: Exposure of the MR image evaluation using the interactive segmentation function of the Able 3D-Doctor Software®, 
exemplary for a T2-weighted coronary MR image
VS represents the vaccination site and CS represents the control side. (a) t2-weighted coronary MR image, representing a region with 
increased signal intensity at the VS. (b) Same MR image with defined ROI (region of interest, white box) around the largest extent  
of the area with increased signal intensity. the area with increased signal is bordered using the interactive segmentation function.  
(c) The ROI is flipped to the CS and regions with increased signal and the same thresholds as the VS are bordered, if existing.
Tab. 3: MRI parameters for the examination of vaccination-induced local reactions in pigs 
For the different age groups (group I & II: 12 weeks old; group III & IV: 6 months old) different MRI protocols had to be used because  
of the different animal sizes. t1wSe = t1-weighted spin echo sequence with coronary and axial acquisition. t2wSe = t2-weighted spin 
echo sequence with coronary acquisition
 group I & II  group III & IV 
 T1wSE T2wSE T1wSE T2wSE
pixel size (mm) 1.67 x 0.90 1.60 x 0.90 2.54 x 1.37 2.50 x 1.37
examination time 5 min 40 sec 5 min 28 sec 5 min 40 sec 5 min 48 sec
time to repeat (TR) 814 ms 5948 ms 814 ms 5690 ms
time to echo (TE) 17 ms 102 ms 17 ms 102 ms
slice number 22 22 22 22
slice thickness 4 mm 4 mm 5 mm 5 mm
acquisition coronary, axial coronary coronary, axial coronary
distance factor 0.50 0.50 1.00 1.00
matrix size  138 x 256 (54%) 126 x 256 (56%) 138 x 256 (54%) 140 x 256 (55%)
field of view  230 mm 230 mm 350 mm 350 mm
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mirrored region of interest of the untreated control (body) side. 
The region of interest was mirrored along the (neck) spine.
3  Results
The results of the F-test and the paired t-test show obvious vol-
ume differences regarding VS and CS (see Vol_diff, Tab. 4). 
These differences are significant (p < 0.05) – in some cases 
highly significant (p < 0.001) – in all used sequences (T1c, T2c) 
on the first day of examination. During follow-up examinations 
(day 3-29) volume differences between VS and CS decreased. 
In some examination groups significant volume differences 
could still be detected at the last day of examination (group III: 
T2c; group IV: T1c, T2c). 
Statistical analysis
The statistical software package SAS 9.3 (SAS Institute Inc., 
Cary, North Carolina, USA) was used for a variance analysis 
procedure, performing an F-test followed by a paired t-test. 
Thus differences between hyperintense volumes of the VS and 
the corresponding CS could be obtained for each sequence and 
vaccination group separately. The significance level was set at 
p < 0.05. 
We used the matched paired t-test because the animals served 
both as control and as treatment groups at the same time. As de-
scribed, one body side served as vaccination site and the oppo-
site body side as control site (without vaccination). Therefore, 
we were dealing with dependent means (standard deviations) de-
rived from volume calculations for voxels with increased signal 
intensities in the region of interest of the vaccination site and the 
Tab. 4: Results of the paired t-test to identify volume differences between the vaccination and the control site 
group day T1-weighted coronary MRI sequence (T1c)            T2-weighted coronary MRI sequence (T2c)
  Vol_diff  ± SD (cm3) p-value Vol_diff ± SD (cm3) p-value
I 1 3.53 ± 0.86 < 0.01 7.78 ± 1.15 < 0.0001
(GnRF) 3 1.88 ± 0.58 < 0.01 1.92 ± 0.51 < 0.01
 8 2.21 ± 0.75 < 0.01 2.02 ± 0.54 < 0.01
 15 1.39 ± 0.42 < 0.01 0.15 ± 0.10 n.s.
 29 1.33 ± 0.98 n.s. -0.74 ± 0.35 < 0.05
II   1 0.46 ± 0.14 < 0.01 0.28 ± 0.11 < 0.05
(Parvovirus) 3 0.71 ± 0.22 < 0.01 0.29 ± 0.11 < 0.05
 8 0.58 ± 0.14 < 0.001 0.12 ± 0.07 n.s.
 15 0.09 ± 0.10 n.s. 0.03 ± 0.04 n.s.
 22 0.13 ± 0.11 n.s. -0.02 ± 0.07 n.s.
 29 0.12 ± 0.13 n.s. 0.11 ± 0.08 n.s.
III 1 0.77 ± 0.25 < 0.01 2.38 ± 0.71 < 0.01
(Parvovirus   3 0.84 ± 0.30 < 0.05 2.44 ± 0.60 < 0.01 
+ E. r. I)
 8 0.47 ± 0.13 < 0.01 2.55 ± 0.60 < 0.001
 15 0.03 ± 0.13 n.s. 2.22 ± 0.54 < 0.001
IV 1 1.31 ± 0.39 < 0.01 1.52 ± 0.52 < 0.05
(Parvovirus   3 2.83 ± 0.60 < 0.001 3.10 ± 1.61 n.s.
+ E. r. II)
 8 2.71 ± 0.64 < 0.001 1.25 ± 0.97 n.s.
 15 1.56 ± 0.47 < 0.01 1.60 ± 0.46 < 0.01
 22 1.02 ± 0.45 < 0.05 2.17 ± 0.55 < 0.01
Because of technical problems no data could be obtained for group I on day 22. Vol_diff describes the volume difference for the 
hyperintense volume at VS and CS. All arithmetic mean volume differences are specified with the corresponding standard deviations (SD) 
and the corresponding result of the paired t-test as p-value. n.s. = not significant (p > 0.05). E. r. = Erysipelothrix rhusiopathiae.
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whereas the mean volume difference of group IV increased on 
the first examination days and decreased from day 15 on (see 
Tab. 4). That shows that MRI can follow different progressions 
of local reactions initiated by different vaccines.
Additionally differences regarding the evaluated volume 
differences between VS and CS were found in this study (Tab. 
4). That means that MRI can be used to rank vaccines regard-
ing their tissue compatibility and this information can lead to a 
risk-benefit-assessment in safety testing of veterinary vaccines. 
This data can further be used to formulate recommendations 
on the animal welfare impact of vaccination – as massive local 
reactions at the injection site do also affect animal welfare. 
It could be postulated that the volume differences between VS 
and CS could be solely caused by a volume effect of the injected 
volume, as volume effects were reported in the literature (Sidell 
et al., 1974; Steiness et al., 1974). As no control injection of sa-
line solution was examined during this study, the volume effect 
cannot be totally excluded in this case. Earlier studies, however, 
have not reported pathologic conditions after administration of 
2 ml of saline solution in pigs (Steiness et al., 1978). However, 
the injection volume in this study was 2 ml for all examina-
tion groups. If the volume effect were the only reason for the 
alterations in the MR images and the corresponding volume dif-
ferences, the volume differences should be comparable for all 
examination and age groups. As shown in the results (Tab. 4), 
the volume differences differed among the examination groups 
(I-IV) and among the age groups (12 weeks old and 6 month 
old). The true volume effect cannot exceed the detected volume 
difference for group II, which was the smallest difference be-
tween injection and control site (Tab. 4). Therefore, these study 
results show that different volume differences are caused mainly 
by different vaccine ingredients. Further studies could evaluate 
a possible volume effect by injecting saline solution in different 
age groups as a control compared to vaccine injections.
In human studies, MRI is used to detect alterations in muscle 
tissue (Lovitt et al., 2006; May et al., 2000; Schrank et al., 2005). 
By choosing different sequence parameters for MR imaging, a 
multitude of pathologic conditions can be illustrated (Berquist 
et al., 1985; Hodgson, 2010). In order to use this potential for 
this study, two different MRI sequence parameters (T1- and T2-
weighted) were used (see Tab. 3). Different pathologic condi-
tions are described in the literature like hematoma, edema, fatty 
infiltration or inflammation, which result in alterations in tissue 
parameters and therefore in an illustration in T1- or T2-weight-
ed MR images. These pathologic conditions result in areas with 
increased signal intensity in T1- and T2-weighted MR images 
(Lovitt et al., 2006; May et al., 2000; Schrank et al., 2005). In 
this study image evaluation was performed by evaluating vol-
umes of regions with hyperintense signals at the VS and CS 
(see Fig. 3). These volumes differed between the different used 
sequences showing different pathologic reactions as described 
in the literature (Lovitt et al., 2006; May et al., 2000; Schrank 
et al., 2005):
1. T2-weighted MR images: 
Regions with hyperintense signals in the T2-weighted MR im-
ages represent edematous tissue or fatty infiltration (May et al., 
The evaluated volume differences (Vol_diff) differed between 
the groups on the same examination day. The highest volume 
differences between VS and CS were found in examination 
group I, no matter which sequence was used; the smallest vol-
ume differences were found in examination group II. 
When we compare T1c and T2c, the evaluated volume dif-
ferences of the four examination groups change as follows (on 
examination day 1): for group I the volume differences were 
doubled, for group II the evaluated mean volume differences 
were halved, for group III the volume differences were tripli-
cated and for group IV a small increase of the mean volume 
differences was observed.
4  Discussion and conclusions
The results of this study showed in each examination group – 
and therefore for every vaccine used – significant differences 
between VS and CS. These differences were significant on the 
first examination days for all groups, independent of the meas-
urement sequence. As the anesthesia was injected into the mus-
cles of the hind leg (M. semitendinosus / M. semimembranosus) 
and changes in the grey scales of the neck muscle tissue only 
can be detected at the VS, it is clear that (1) interactions of the 
vaccine with other injections can be excluded and that (2) the 
hyperintense region inside the muscle tissue of VS represents 
the local reaction caused by the injected vaccine. These results 
show that MRI allows detection and evaluation of three-dimen-
sional local reactions within muscular and subcutaneous tis-
sues caused by the injection of vaccines. These data, obtained 
in pigs, are in line with results of human studies, where MRI 
has been used to detect and monitor muscular damage (Fisher 
et al., 1986; Lovitt et al., 2006; Messineo et al., 1998; Schrank 
et al., 2005). 
Additionally, this study showed that repeated MRI examina-
tions of the same animal allow description of the progress of 
local reactogenicity individually for each animal. For example, 
group I showed (on day 1 for sequence T1c) an average volume 
difference of 3.53 ±0.86 cm3, which decreased until day 29 to 
an average volume difference of 1.33 ±0.98 cm3 (see Tab. 4). 
In comparison, histopathologic examinations of animals, which 
are currently used in safety testing, offer only single snap shots 
of individual animals. The possibility to evaluate local reactions 
using follow-up examinations in living pigs by MRI – like it 
is used in humans – means that the animals do not have to be 
killed to identify possible reactions after vaccination by a post 
mortem examination. Animals can stay in the clinical trial until 
no further reaction is visible in MR images or until the reac-
tion has reached an extent that compromises the animal’s well-
being. In conclusion, the use of MRI in clinical safety studies 
can contribute to reliable and well-documented safety data and 
allows an overall reduction of the number of animals needed to 
perform such trials. 
Furthermore, this study also showed that local reactogenic-
ity varies between groups and therefore between vaccines (see 
Tab. 4). For example, the mean volume difference of group I 
decreased continuously from examination day 1 to day 29, 
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ment the extent and the severity of a local reaction may also be a 
helpful tool to standardize safety evaluations of injectable veteri-
nary medicines, especially vaccines.
To sum up, the use of MRI in clinical safety studies offers 
reliable and well-documented safety data, which could allow an 
overall reduction of the number of animals needed to perform 
such trials. 
A proof of principle is necessary to establish this method as a 
standard tool for safety testing.
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and were significant on day 1 in all groups (see Tab. 4). The 
detected volume differences varied depending on the vaccine 
used. In group I, a volume difference of 7.78 ±1.15 cm3 was 
detected on day 1 (T2c), the smallest edematous volume differ-
ence (0.28 ±0.11 cm3, day 1) was found in group II. Addition-
ally, the volumes of the edematous tissue in this study differed 
in their progression. For group IV, the edematous volume dif-
ference increased until day 3 and then decreased. For group I a 
continuous decrease in volume difference was detected. These 
variations seem to be caused by the effective parts of the differ-
ent vaccines (i.e., adjuvants, preservatives or other ingredients). 
The ingredients seem to determine the extent and duration of an 
edematous reaction. Each used vaccine in this study differed in 
its composition. This assumption is confirmed by human stud-
ies which displayed different local reactions caused by different 
adjuvants (Batista-Duharte et al., 2013; Edelman, 1980; Gupta 
et al., 1993). 
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Cánoves, 2010). 
2. T1-weighted MR images: 
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before, during this study the anesthesia injections were given 
into the ham muscle in order to avoid interdependencies. In case 
of fat tissue or especially fatty infiltration, the hyperintense ar-
eas would be spread evenly on both neck sides (VS and CS), if 
apparent. Therefore, all regions with hyperintense signal inside 
T1-weighted images can be backtracked to inflammatory reac-
tions due to the vaccination.
In conclusion, this study demonstrates that MRI, as a non-invasive 
tool, is suitable to detect, monitor and evaluate local reactions in 
clinical safety tests of pig vaccines. This method has the potential 
to reduce the number of animals used in safety tests for veterinary 
vaccines. Animals can be monitored individually at several time 
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liable method. Using appropriate software, this evaluation method 
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of age categories. The development of a scoring system to docu-
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